VIVOS THERAPEUTICS INC (VVOS) Institutional Ownership Changes & 13F Activity

VIVOS THERAPEUTICS INC (VVOS). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings (Q1 2026). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions in the latest reporting period. Notable filers include Armistice Capital, Llc, Drw Securities, Llc, Iht Wealth Management, Llc, Geode Capital Management, Llc, and Centurion Wealth Management Llc.

InstitutionTypeChange in sharesChange Position %SharesReported stock balancePortfolio quarterFiling date
Armistice Capital, LlcBuy+1,115,859—1,115,859$1.32MQ1 2026May 15, 2026
Iht Wealth Management, LlcBuy+41,061—41,061$48.45KQ1 2026May 15, 2026
Geode Capital Management, LlcBuy+39,256+69.7%95,543$112.74KQ1 2026May 15, 2026
Xtx Topco LtdBuy+25,117—25,117$29.64KQ1 2026May 15, 2026
Tower Research Capital Llc (Trc)Buy+4,423+149.2%7,388$8.72KQ1 2026May 15, 2026
Northwestern Mutual Wealth Management CoBuy+3—3$4.00Q1 2026May 07, 2026
Ubs Group AgSell-1,631-12.9%11,046$13.04KQ1 2026May 05, 2026
Sequoia Financial AdvisorsBuy+24,000—24,000$28.32KQ1 2026Apr 30, 2026
B. Riley Wealth Advisors, Inc.Sell-5,465-12.6%38,066$41.49KQ1 2026Apr 27, 2026
Commonwealth Equity Services, LlcBuy+2,000+4.9%42,500$50.15KQ1 2026Apr 27, 2026
Centurion Wealth Management LlcBuy+35,684—35,684$42.11KQ1 2026Apr 13, 2026
Bank Of America CorpSell-132-100.0%0$0.00Q1 2026Feb 17, 2026
Drw Securities, LlcSell-115,907-100.0%0$0.00Q1 2026Feb 12, 2026
Showing 13 of 13

Frequently asked questions about VVOS activity

  • Which institutional owners are buying VVOS?

    Institutional owners buying VVOS include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.

  • What does "buy" mean in VVOS activity?

    "Buy" means an investor increased their reported position in VVOS compared to the prior reporting period. This reflects growing exposure to VIVOS THERAPEUTICS INC (VVOS) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).

  • Is institutional interest in VVOS increasing?

    Institutional interest in VVOS can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.